Folate, vitamin B12, and neuropsychiatric disorders

Nutrition Reviews

Volumn 54, Issue 12, 1996, Pages 382-390

  Bottiglieri, Teodoro ^a,b  

^a BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE;

CYANOCOBALAMIN DEFICIENCY; DEMENTIA; DEMYELINATING DISEASE; DEPRESSION; FOLIC ACID DEFICIENCY; HUMAN; MONOAMINE METABOLISM; NEUROPSYCHIATRY; NEUROTOXICITY; REVIEW; METABOLISM; METHYLATION; MULTIPLE SCLEROSIS; PHYSIOLOGY;

DEPRESSIVE DISORDER; FOLIC ACID; FOLIC ACID DEFICIENCY; HOMOCYSTEINE; HUMANS; METHYLATION; MULTIPLE SCLEROSIS; VITAMIN B 12; VITAMIN B 12 DEFICIENCY;

EID: 0030299046     PISSN: 00296643     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1753-4887.1996.tb03851.x     Document Type: Article

References (59)

1. Chanarin I. The Megaloblastic Anaemias. Oxford, UK: Blackwell Publishing, 1979
2. Shorvon SD, Carney MWP, Chanarin I, et al. The neuropsychiatry of megaloblastic anaemia. Br Med J 1980;281:1036-8
3. Agamanolis DP, Green R, Harris JW. The neuropathy of cobalamin deficiency. In Dreosti IE, Smith RM, eds. Neurobiology of Trace Elements. Clifton, NJ: Humana Press, 1983
4. Reynolds EH, Stramentinoli G. Folic acid, S-adenosylmethionine and affective disorder. Psychol Med 1983;13:705-10
5. Scott JM, Dinn JJ, Wilson P, et al. Pathogenesis of subacute combined degeneration: a result of methyl group deficiency. Lancet 1987;2:334-7
6. Stabler SP, Marcell PD, Podell ER, et al. Elevation of total homocysteine in the serum of patients with cobalamin or folate deficiency detected by capillary gas chromatography-mass spectrometry. J Clin Invest 1988;81:466-74
7. Ueland PM, Refsum H, Stabler S, Malinow MR, Andersson A, Allen AH. Total homocysteine in plasma or serum: methods and clinical applications. Clin Chem 1993;39:1764
8. Cantoni GL. The centrality of S-adenosylhomocysteine in the regulation of the biological utilization of S-adenosylmethionine. In: Borchardt RT, Cyrus RG, Ueland PM, eds. Biological Methylation and Drug Design: Experimental and Clinical Roles of SAM. Clifton, NJ: Humana Press Inc, 1987:227-37
9. Carney, MWP. Serum folate values in 423 psychiatric patients. Br Med J 1967;4:512-16
10. Young SN, Ghadirian AM. Folic acid and psychopathology. Prog Neuropsychopharmacol Biol Psychiatry 1989;13:841-63
11. Carney MWP, Chary TK, Laundy M, et al. Red cell folate concentrations in psychiatric patients. J Affective Disord 1990;19:207-13
12. Botez MI, Young SN, Bachevalier J, et al. Folate deficiency and decreased brain 5-hydroxytryptamine in man and rat. Nature 1979;278:182-3
13. Botez MI, Young SN. Effects of anitconvulsants and low levels of folate and thiamine on amine metabolites in cerebrospinal fluid. Brain 1991;114:333-48
14. Bottiglieri T, Hyland K, Laundy M, et al. Folate deficiency, biopterin and monoamine metabolism in depression. Psychol Med 1992;22:871-6
15. Bottiglieri T, Hyland K, Laundy M, et al. Folate deficiency, homocysteine and monoamine metabolism in depression. Pteridines 1992;3:151-2
16. Hyland K, Smith I, Bottiglieri T, et al. Demyelination and decreased S-adenosylmethionine in 5,10-methylentetrahydrfolate reductase deficiency. Neurology 1988;38:459-62
17. Surtees R, Heales S, Bowron A. Association of cerebrospinal fluid deficiency of 5-methyltetrahydrofolate, but not S-adenosylmethionine, with reduced concentrations of the acid metabolites of 5-hydroxytryptamine and dopamine. Clin Sci 1994;86:697-702
18. Ruck A, Kramer S, Metz J, Brennan M. Methytetrahydrofolate is a potent and selective agonist for kanic acid receptors. Nature 1980;287:852-3
19. Wang J, Andrews H, Thukral V. Presynaptic recptors regulate noradrenaline release from isolated nerve terminals. J Neurochem 1992;58:204-11
20. Coppen A, Abou-Saleh MT. Plasma folate and affective morbidity during long term litium therapy. Br J Psychiatry 1982;141:87-9
21. Godfrey PS, Toone BK, Carney WMP, et al. Enhancement of recovery from psychiatric illness by methylfolate. Lancet 1990;336:392-5
22. Freidal HA, Goa KL, Benfeild P. S-adenosylmethionine: a review of its pharmacological properties and therapeutic potential in liver dysfunction and affective disorders in relation to its physiological role in cell metabolism. Drugs 1989;38 389-416
23. Goodwin JS, Goodwin JM, Garry PJ. Association between nutritional status and cognitive functioning in a healthy elderly population. JAMA 1983;249:2917-21
24. Bell IR, Edman JS, Marby DW, et al. Vitamin B12 and folate status in acute psychogeriatric inpatients: affective and cognitive characteristics of a vitamin nondeficient population. Biol Psychiatry 1990;27: 125-37
25. Greer A, McBride D, Shenkin A. Comparison of the nutritional state of new and long-term patients in a psychogeriatric unit. Br J Psychiatry 1986;149:738-41
26. 12 levels in serum and cerebrospinal fluid of people with Alzheimer's dementia. Acta Psychiatr Scand 1990;82;327-9 27.
27. Nijst TQ, Weavers RA, Schoonderwaldt HC, Hommes OR, de Mann, AF. Vitamin B12 and folate concentrations in serum and cerebrospinal fluid of neurological and psychiatric patients with special reference to multiple sclerosis and dementia. J Neurol Neurosurg Psychiatr 1990;53:951-4
28. Bottiglieri T, Godfrey P, Flynn T et al. Cerebrospinal fluid S-adenosylmethionine in depression and dementia: effects of treatment with parenteral and oral S-adenosylmethionine. J Neurol Neurosurg Psychiatry 1990;53:1096-8
29. Reynolds EH, Godfrey P, Bottiglieri T, Carney MWP, Toone BK. S-adenosylmethionine and Alzheimer's disease. [Abstract] Neurol 1989;39(suppl 1):397
30. Fontanari D, Di Palma C, Giorgetti G, Violante F, Violante M. Effects of S-adenosyl-L-methionine on cognition and vigilance functiond in the elderly. Curr Therap Res 1994;55:682
31. 12 metabolism in multiple sclerosis. Arch Neurol 1992;42:649-52
32. Crellin RF, Bottiglieri T, Reynolds EH. Multiple sclerosis and macrocytosis. Acta Neurol Scand 1991;81: 388-91
33. Najim al-Din AS, Khojali M, Habbosh H, et al. Macrocytosis in multiple sclerosis: a study of 82 de novo Arab patients. J Neurol Neurosurg Psychiatry 1991;54:415-6
34. Goodkin DE, Jacobsen DW, Galvez N, Daughtry M, Secic M, Green R. Serum cobalamin deficiency is uncommon in multiple sclerosis. Arch Neurol 51: 1994;1110-4
35. Kira J, Tobimatsu S, Goto I (1994) Vitamin B12 metabolism and massive-dose methyl vitamin B12 therapy in Japanese patients with multiple sclerosis. Intern Med 33:82-86
36. Sigel SH, Hall CA, Antel JP (1987) Plasma R binder deficiency and neurologic disease. N Engl J Med 317:1330-2
37. Carmel R, Watkins D, Goodman SI, et al. Hereditary defect of cobalamin (CbIG mutation) presenting as a neurological disorder in adulthood. N Engl J Med 1988;318:1738-41
38. Ransohoff RM, Jacobsen DW, Green R. Vitamin B12 deficiency and multiple sclerosis. [letter] Lancet 1990;335:1285-6
39. Pincus, JH (1979) Folic acid deficiency: a cause of subacute combined system degeneration. In: Botez MI, Reynolds EH, eds. Folic Acid in Neurology, Psychiatry and Internal Medicine. New York, NY: Raven Press, 1979:427-33
40. Lever EG, Elwes RDC, Williams A, Reynolds EH. Subacute combined degeneration of the cord due to folate deficiency: response to methyl folate treatment. J Neurol Neurosurg Psychiatr 1985;49:1203-7
41. Jacobson W, Grandy G, Sidman RL. Experimental subacute combined degeneration of the cord in mice. J Pathol 1973;109:S13-4
42. Lee CC, Surtees R, Duchen LW. Distal motor axonopathy and central nervous system vacuolation caused by cycloleucine, an inhibitor of methionine adenosyltransferase. Brain 1992;115:935-55
43. Scott JM, Dinn J, Wilson P, Weir DG. Pathogenesis of subacute combined degeneration: a result of methyl group deficiency. Lancet 1981;ii:334-7
44. van der Westhuyzen J, Fernandes-Costa F, Metz J. Cobalamin inactivation by nitrous oxide produces severe neuological impairment in fruit bats: protection by methionine and aggravation by folates. Life Sci 1982;31:2001-10
45. Weir DG, Keating JN, McParhin J, et al. Methylation deficiency causes vitamin B12 associated neuropathy in the pig. J Neurochem 1988;51:1949-52
46. Weir DG, Molloy AM, Keating JN, et al. Correlation of the ratio of S-adenosylmethionine to S-adenosyl-L-homocysteine in the brain and cerebrospinal fluid of the pig: implications for the determination of this methylation ratio in human brain. Clin Sci 1992;82: 93-7
47. Viera-Makings E, Metz J, van der Westhuyzen J, Bottiglieri T, Chanarin I. Cobalamin neuropathy: is S-adenosylmethionine toxicity a factor? Biochem J 1990;266:707-11
48. Bottiglieri T, Hyland K, Laundy M, Reynolds EH. Deficiency of CNS S-adenosylmethionine and impaired methylation in subacute combined degeneration. [Abstract] Trans Am Soc Neurochem 1994;25(1):30B
49. Surtees R, Leonard J, Austin S. Association of demyelination with deficiency of cerebrospinal fluid S-adenosylmethionine in inborn errors of methyltransfer pathway. Lancet 1991;338:1550-4
50. 12) and folate deficiency. FASEB J 1993;7:1344-53
51. 3H]histamine in vivo after S-adenosylmethionine administration. J Pharmacol Exp Ther 1981;216:118
52. Schatz RA, Wilens TE, Sellinger OZ. Decreased in vivo protein and phopholipid methylation after in vivo elevation of brain S-adenosylhomocysteine. Biochem Biophys Res Commun 1981;98:1097
53. Do KQ, Herrling PL, Streit P, Cuenod M. Release of neu reactive substances: homocysteic acid as an endogenous agonist of the NMDA receptor. J Neural Transm 1989;72:185
54. Cuenod M, Grandes P, Zangerle L, Streit P, Do KQ. Sulphur containing excitatory amino acids in intracellular communication. Biochem Soc Trans 1993;21:72
55. Ohmori S, Kodama H, Ikegami T, Mizuhara S. Unusal sulfur containing amino acids in the urine of homocystinuric patients: III. Homocysteic acid, homosteine sulfinic acid (carboxymethylthio) homocysteine, and s- (3-hydroxy-3-carboxy-n-propyl) homocysteine. Physiol Chem Physics 1972;4:286
56. Shaw PJ. Excitatory amino acid receptors, excitotoxcity and the human nervous system. Curr Opin Neuro Neurosurg 1993;6:414
57. Olney JW. Excitatory amino acids and neuropsychiatric disorders. Biol Pyschiatry 1989;26:506
58. Smirnova T, Skinnakre J, Mallet J. Characterization of a presynaptic glutamate receptor. Science 1993;262:430
59. Santhosh-Kumar CR, Hassell KL, Deutsch JC, Kolhouse JF. Are neuropsychiatric manifestations of folate, cobalamin and pyridoxine deficiency mediated through imbalances in excitatory sulfur amino acids? Med Hypotheses 1994;43:239-44